Endoscopic Ultrasound-Guided Gastroenterostomy for Malignant Gastric Outlet Obstruction
Malignant Gastric Outlet Obstruction
About this trial
This is an interventional treatment trial for Malignant Gastric Outlet Obstruction focused on measuring EUS-Guided gastro-enterostomy, Safety, Efficacy
Eligibility Criteria
Inclusion Criteria:
Patients of both genders over 18 years of age with gastric outlet obstruction syndrome secondary to stage III or more at gastric, duodenal or pancreatic cancer who are candidates for palliative treatment, who do not want surgical treatment.
Diagnosis confirmed as follows:
- Histopathological report of cancer.
- Simple and contrasted thoracoabdominal tomography.
- Tolerance to oral feeding based on liquids only or null.
Exclusion Criteria:
Patients who do not accept the signing of the informed consent.
- Postoperative patients with Roux-en-Y gastrojejunostomy.
- Patients with large volume ascites.
- Patients with malignant obstruction distal to the jejunal puncture.
- Pregnant women.
- Patients with a Karnofsky index less than 50 or an E.C.O.G. greater than or equal to 4 points.
- Patients in whom any endoscopic procedure has been contraindicated for any reason.
- Patients who want to undergo surgical treatment as an initial option.
- Patients with malignant biliary obstruction without endoscopic treatment at the time of gastric outflow tract obstruction presentation.
Elimination Criteria:
- Patients who undergo the endoscopic procedure but cannot be completed due to transmural invasion of malignancy, hemorrhage or inability to puncture the intestinal loop with any method described, puncture site> 2cm away from the gastric wall or inability to pass the guidewire through obstruction (unless direct technique is performed).
- Patients who do not attend follow-up.
Sites / Locations
- Centro Medico Nacional Siglo XXI Hospital de EspecialidadesRecruiting
Arms of the Study
Arm 1
Experimental
EUS-guided gastroenterostomy in malignant gastric outlet obstruction
The patients with malignant gastric outlet obstruction will be confirmed as follows: Histopathological report of cancer, thoracoabdominal tomography and impaired tolerance to oral feeding (tolerance to liquids only or null).